Vigil Neuroscience (VIGL) Competitors $8.05 0.00 (0.00%) As of 08/5/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VIGL vs. NVTS, SDGR, AVDL, ARDX, JANX, HROW, VERA, AMPH, SNDX, and ETNBShould you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Navitas Semiconductor (NVTS), Schrodinger (SDGR), Avadel Pharmaceuticals (AVDL), Ardelyx (ARDX), Janux Therapeutics (JANX), Harrow (HROW), Vera Therapeutics (VERA), Amphastar Pharmaceuticals (AMPH), Syndax Pharmaceuticals (SNDX), and 89BIO (ETNB). Vigil Neuroscience vs. Its Competitors Navitas Semiconductor Schrodinger Avadel Pharmaceuticals Ardelyx Janux Therapeutics Harrow Vera Therapeutics Amphastar Pharmaceuticals Syndax Pharmaceuticals 89BIO Navitas Semiconductor (NASDAQ:NVTS) and Vigil Neuroscience (NASDAQ:VIGL) are related small-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership. Which has more risk and volatility, NVTS or VIGL? Navitas Semiconductor has a beta of 3, suggesting that its stock price is 200% more volatile than the S&P 500. Comparatively, Vigil Neuroscience has a beta of 3.33, suggesting that its stock price is 233% more volatile than the S&P 500. Do analysts recommend NVTS or VIGL? Navitas Semiconductor presently has a consensus price target of $5.65, suggesting a potential downside of 1.40%. Vigil Neuroscience has a consensus price target of $10.80, suggesting a potential upside of 34.16%. Given Vigil Neuroscience's higher probable upside, analysts clearly believe Vigil Neuroscience is more favorable than Navitas Semiconductor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Navitas Semiconductor 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29Vigil Neuroscience 0 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NVTS or VIGL more profitable? Vigil Neuroscience has a net margin of 0.00% compared to Navitas Semiconductor's net margin of -182.63%. Navitas Semiconductor's return on equity of -18.16% beat Vigil Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Navitas Semiconductor-182.63% -18.16% -16.26% Vigil Neuroscience N/A -111.70%-74.67% Do insiders & institutionals hold more shares of NVTS or VIGL? 46.1% of Navitas Semiconductor shares are owned by institutional investors. Comparatively, 83.6% of Vigil Neuroscience shares are owned by institutional investors. 29.9% of Navitas Semiconductor shares are owned by company insiders. Comparatively, 18.0% of Vigil Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to NVTS or VIGL? In the previous week, Navitas Semiconductor had 12 more articles in the media than Vigil Neuroscience. MarketBeat recorded 12 mentions for Navitas Semiconductor and 0 mentions for Vigil Neuroscience. Navitas Semiconductor's average media sentiment score of 0.61 beat Vigil Neuroscience's score of 0.00 indicating that Navitas Semiconductor is being referred to more favorably in the media. Company Overall Sentiment Navitas Semiconductor Positive Vigil Neuroscience Neutral Which has higher earnings & valuation, NVTS or VIGL? Vigil Neuroscience has lower revenue, but higher earnings than Navitas Semiconductor. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNavitas Semiconductor$83.30M14.66-$84.60M-$0.65-8.82Vigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93 SummaryNavitas Semiconductor beats Vigil Neuroscience on 9 of the 15 factors compared between the two stocks. Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIGL vs. The Competition Export to ExcelMetricVigil NeuroscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$383.91M$3.10B$5.75B$9.83BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-3.9321.2382.4426.63Price / SalesN/A398.88530.80110.54Price / CashN/A43.5325.7028.92Price / Book4.608.1310.646.56Net Income-$84.26M-$53.35M$3.28B$266.04M7 Day PerformanceN/A0.45%-0.08%-0.58%1 Month PerformanceN/A9.94%10.36%6.24%1 Year Performance126.12%11.73%49.00%22.21% Vigil Neuroscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIGLVigil Neuroscience1.4396 of 5 stars$8.05flat$10.80+34.2%N/A$383.91MN/A-3.9340NVTSNavitas Semiconductor2.0472 of 5 stars$6.20-3.6%$5.65-8.9%+90.7%$1.37B$83.30M0.00160SDGRSchrodinger2.7067 of 5 stars$19.54-3.8%$27.83+42.4%-9.1%$1.50B$207.54M-7.88790Positive NewsAVDLAvadel Pharmaceuticals3.7123 of 5 stars$14.81-2.8%$19.67+32.8%-1.3%$1.48B$169.12M-493.6770News CoverageAnalyst ForecastARDXArdelyx4.4919 of 5 stars$6.06-0.8%$11.50+89.8%+3.6%$1.47B$333.61M-26.3590News CoveragePositive NewsAnalyst UpgradeJANXJanux Therapeutics3.1031 of 5 stars$23.01-5.3%$86.90+277.7%-51.3%$1.46B$10.59M0.0030News CoveragePositive NewsHROWHarrow3.5111 of 5 stars$37.36-4.5%$64.67+73.1%-6.8%$1.45B$199.61M0.00180VERAVera Therapeutics2.8204 of 5 stars$21.34-5.4%$63.00+195.2%-40.2%$1.44BN/A0.0040News CoveragePositive NewsAMPHAmphastar Pharmaceuticals3.3964 of 5 stars$29.83-2.2%$31.50+5.6%-36.8%$1.42B$731.97M11.172,028Positive NewsSNDXSyndax Pharmaceuticals4.4124 of 5 stars$15.66-3.6%$38.00+142.7%-21.6%$1.40B$23.68M0.00110News CoveragePositive NewsETNB89BIO2.5642 of 5 stars$9.10-3.5%$26.63+192.6%-3.3%$1.40BN/A0.0040News CoveragePositive News Related Companies and Tools Related Companies NVTS Competitors SDGR Competitors AVDL Competitors ARDX Competitors JANX Competitors HROW Competitors VERA Competitors AMPH Competitors SNDX Competitors ETNB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIGL) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vigil Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
